FIELD: medicine.
SUBSTANCE: anticancer agent representing recombinant human cyclophilin A in the form of phosphate buffer solution is a producer of the strain Escherichia coli (BL21(DE3)Gold/pETCYPopti deposited in the Russian National Collection of Industrial Microorganisms of FGUP GosNII Genetika (Federal State Unitary Enterprise State Research Institute of Genetics) under registration No. B-11983 of July 18th, 2014. The agent described above possess a pronounced anticancer activity on mammary adenocarcinoma Ca755, cervical cancer (cervical cancer 5), melanoma B16 and Lewis lung carcinoma (LLC).
EFFECT: higher efficacy of using the agent.
4 tbl
Title | Year | Author | Number |
---|---|---|---|
DERIVATIVE OF THE CLASS OF N-GLYCOSIDES INDOLO[2,3-A]PYRROLO[3,4-C]CARBAZOLE-5,7-DIONE - N-{12-(β-D-XYLOPYRANOSYL)-5,7-DIOXO-INDOLO[2,3-A]PYRROLO[3,4-C]CARBAZOL-6-YL} PYRIDINE-2-CARBOXAMIDE, WHICH HAS CYTOTOXIC AND ANTITUMOR ACTIVITY | 2017 |
|
RU2667906C1 |
N-GLYCOSIDES OF INDOLO[2,3-a]PYRROLO[3,4-c]CARBAZOLES HAVING ANTITUMOUR ACTIVITY | 2014 |
|
RU2548045C1 |
TUMOUR THERAPY AGENT | 2019 |
|
RU2726801C1 |
PHOSPHOLIPID COMPOSITION OF DOXORUBICIN FOR TREATING PATIENTS WITH BREAST CANCER | 2019 |
|
RU2714137C1 |
ANTITUMOUR AGENT | 2014 |
|
RU2572691C1 |
ANTI-TUMOUR PREPARATION | 2014 |
|
RU2569729C1 |
MEDIUM WITH ANTI-TUMOUR EFFECT AND METHOD OF ITS OBTAINMENT | 2007 |
|
RU2349317C1 |
AGENT AND METHOD FOR TREATMENT AND PROPHYLAXIS OF ONCOLOGY DISEASES | 2005 |
|
RU2283658C1 |
AGENT WITH ANTITUMOUR AND ANTIMETASTATIC ACTIVITY, ANTI-INFLAMMATORY AND ANTIALLERGIC ACTION | 2018 |
|
RU2686672C1 |
IMMUNOSTIMULATING PREPARATION POSSESSING ANTI-TUMOR ACTIVITY | 2015 |
|
RU2597837C1 |
Authors
Dates
2016-02-20—Published
2014-11-07—Filed